Poisoning Treatment — Cost, Top Hospitals & Success Rates | MyMedicPlus

Poisoning is defined as harm resulting from exposure to a toxic substance at sufficient dose to cause cellular or organ dysfunction. It may be accidental (particularly in young children), intentional (self-poisoning or assault), occupational, or iatrogenic (drug overdose or adverse effect). Poisoning is one of the most common reasons for emergency department attendance worldwide, with over 2 million calls to poison control centres in the United States annually. Pharmaceutical drug overdoses (paracetamol/acetaminophen, opioids, benzodiazepines, tricyclic antidepressants, antipsychotics) are the predominant cause in high-income countries; agricultural pesticides (organophosphates, carbamates, rodenticides) and industrial chemicals cause the majority of severe poisoning in low- and middle-income countries.

The emergency assessment of the poisoned patient uses the same systematic ABCDE approach as any critically unwell patient, with particular attention to the toxic syndrome (toxidrome) — a constellation of signs and symptoms characteristic of a specific class of poison that guides management. The five principal toxidromes are: cholinergic (organophosphates, nerve agents — causing salivation, lacrimation, urination, defaecation, emesis, miosis, bradycardia, bronchospasm), anticholinergic (antihistamines, tricyclics — causing dry skin and mucous membranes, urinary retention, tachycardia, mydriasis, delirium), sympathomimetic (cocaine, amphetamines, caffeine — causing tachycardia, hypertension, hyperthermia, agitation, diaphoresis), opioid (heroin, morphine, fentanyl — causing miosis, respiratory depression, reduced consciousness, bradycardia), and serotonin syndrome (SSRIs, MAOIs, triptans — causing hyperthermia, autonomic instability, neuromuscular abnormalities).

Identification of the poison through history, clinical syndrome, and targeted investigations (paracetamol and salicylate levels in all presentations of uncertain overdose, toxicological urine screen, ECG for QT prolongation and QRS widening, metabolic acidosis on blood gas) is essential. The National Poisons Information Service (NPIS in the UK) and TOXBASE database, American Association of Poison Control Centers (AAPCC), and similar services globally provide specialist toxicology advice 24 hours a day to guide management of complex poisonings.

Emergency poisoning treatment addresses the full spectrum of toxic exposures. Paracetamol (acetaminophen) overdose is the most common single agent poisoning in many countries and a leading cause of acute liver failure — it is treatable with N-acetylcysteine if identified and treated within 8–10 hours of ingestion. The Rumack-Matthew nomogram plots paracetamol plasma concentration against time post-ingestion to guide treatment decisions. Salicylate (aspirin) poisoning causes a complex acid-base disturbance (respiratory alkalosis superimposed on metabolic acidosis) and potentially fatal pulmonary oedema and cerebral oedema, requiring specific management with urinary alkalinisation and, in severe cases, haemodialysis.

Opioid overdose — now at epidemic proportions in North America due to illicitly manufactured fentanyl and its analogues — presents with the classic triad of reduced consciousness, respiratory depression, and miosis. Naloxone (an opioid antagonist) is the specific antidote, administered IM, IV, or intranasally in pre-hospital and emergency settings; repeated doses or infusion may be required for long-acting opioids. Benzodiazepine overdose causes sedation and respiratory depression; flumazenil (a benzodiazepine antagonist) is available but its use is restricted to specific scenarios due to risk of precipitating seizures in dependent patients. Tricyclic antidepressant (TCA) overdose causes life-threatening ventricular arrhythmias (QRS prolongation, ventricular fibrillation) and hypotension, treated with sodium bicarbonate; organophosphate pesticide poisoning causes a severe cholinergic crisis treated with atropine and pralidoxime.

All patients with known or suspected significant poisoning require emergency medical assessment. Even patients who appear well initially after a toxic exposure may deteriorate — particularly with paracetamol (which causes no immediate symptoms but fatal hepatotoxicity appearing 24–72 hours later), slow-release drug formulations, and certain toxins with delayed action (paraquat, colchicine, anticoagulant rodenticides). Risk stratification using validated overdose scoring tools (paracetamol nomogram, TOXBASE risk assessments for specific agents) determines the appropriate level of care.

Poisoned patients with compromised airway, reduced consciousness (GCS below 8), significant haemodynamic instability, severe metabolic acidosis, or seizures require immediate resuscitation and ICU monitoring. Patients with intentional self-poisoning require psychiatric assessment after medical stabilisation — liaison psychiatry involvement should be initiated early in the emergency department stay. Children with accidental ingestion of potentially toxic household products or medications require prompt poison control centre advice even if apparently asymptomatic, as some agents are particularly toxic in small doses in children (e.g., iron tablets, methadone, cardiovascular drugs, opioid patches).

Poisoning management follows four principles: supportive care, decontamination, antidotes, and enhanced elimination. Supportive care — maintaining airway, breathing, and circulation; treating seizures and arrhythmias; managing metabolic disturbances — is the foundation for virtually all poisonings as most have no specific antidote. Endotracheal intubation for airway protection is required in patients with GCS below 8, impaired gag reflex, or risk of aspiration.

Gastrointestinal decontamination aims to reduce absorption of ingested toxins. Activated charcoal (50 g orally or via nasogastric tube) binds many organic compounds in the gut and reduces absorption if given within 1 hour of ingestion; it is appropriate for patients who are awake and cooperative with a protected airway. Gastric lavage (stomach washout) is rarely used today due to limited evidence and risk of aspiration; it may be considered for very recent ingestion of a lethal dose of a toxin not adsorbed by charcoal. Specific antidotes exist for a minority of poisons and represent targeted life-saving interventions: N-acetylcysteine for paracetamol, naloxone for opioids, digoxin-specific antibody fragments for digoxin toxicity, hydroxocobalamin for cyanide poisoning, calcium and glucagon for calcium channel blocker overdose, vitamin K and fresh frozen plasma for anticoagulant rodenticides. Enhanced elimination techniques — multiple dose activated charcoal (MDAC), urinary alkalinisation for salicylates, haemodialysis for salicylates, methanol, ethylene glycol, and lithium toxicity — accelerate removal of certain toxins from the body.

Prompt recognition and treatment of poisoning substantially reduces mortality. Most pharmaceutical drug overdoses treated promptly in emergency departments have survival rates exceeding 95%. Paracetamol overdose treated with N-acetylcysteine within 8 hours of ingestion almost universally avoids significant hepatotoxicity; liver failure risk rises steeply with delayed treatment. Opioid overdose treated promptly with naloxone is rapidly reversible — naloxone typically restores consciousness and adequate breathing within 2 minutes of administration.

The impact of poison control centres and toxicological advisory services on outcomes is well documented: regions with 24-hour poison control centre access demonstrate lower poisoning mortality and fewer unnecessary hospital admissions for minor exposures. Activated charcoal, when appropriate and given early, reduces drug absorption by 50–70% for many agents. For patients with severe poisoning requiring ICU admission and mechanical ventilation, modern critical care achieves survival rates that would have been impossible in previous decades, with the majority surviving without permanent organ damage when the acute toxic episode is survived.

The complications of poisoning depend critically on the toxic agent. Paracetamol overdose causing acute liver failure has a mortality of approximately 30% without transplantation; liver transplantation (using the King's College criteria to guide selection) can be life-saving in severe cases. Organophosphate poisoning causing severe cholinergic crisis requires prolonged ICU management with high-dose atropine and can cause permanent neurological sequelae. Paraquat ingestion (a herbicide) causes delayed progressive pulmonary fibrosis that is almost invariably fatal above certain doses despite aggressive treatment.

Management complications include aspiration pneumonia in patients who vomit after activated charcoal administration (particularly if consciousness is reduced), arrhythmias precipitated by tricyclic antidepressant or QT-prolonging drug toxicity, seizures from theophylline, cocaine, or chloroquine overdose, and hypokalaemia and hypophosphataemia from aggressive treatment of salicylate poisoning with bicarbonate infusion. Naloxone administration in opioid-dependent patients may precipitate acute opioid withdrawal with severe agitation and risk of violence. Psychological complications — depression, PTSD, repeated self-harm — are common in patients presenting with intentional self-poisoning and require proactive psychiatric follow-up.

Physical recovery after uncomplicated pharmaceutical drug overdose is typically complete within 24–48 hours for most short-acting agents. Patients with paracetamol-induced hepatotoxicity require monitoring of liver function tests (ALT, INR, creatinine) over several days; most recover with N-acetylcysteine treatment, with INR normalisation by days 3–5. Organ function monitoring for renal toxicity (paracetamol, ethylene glycol, myoglobin from rhabdomyolysis), cardiac toxicity (electrolyte monitoring, ECG), and haematological toxicity is maintained until toxicity is confirmed resolved.

For patients with intentional self-poisoning — the majority of pharmaceutical overdose presentations in adolescents and adults — psychiatric assessment before discharge is essential and in most countries is a mandatory component of care. Assessment by a liaison psychiatrist or psychiatric nurse covers mental state, risk of recurrence, underlying mental health diagnoses, social circumstances, and the safety of discharge. Outpatient or community mental health follow-up, crisis helpline information, and safety planning (e.g., reducing access to means of self-harm) are arranged before discharge. Substance misuse services should be involved for patients with alcohol or drug-related presentations.

Emergency poisoning treatment is a non-elective service covered by health insurance or national health systems in most countries. In the US, an emergency department visit for a drug overdose without ICU admission typically costs $5,000–15,000; ICU admission for severe poisoning can reach $50,000 or more per episode. The opioid epidemic has placed enormous financial burden on US emergency services, estimated at over $78 billion annually in healthcare, law enforcement, and lost productivity costs.

For follow-up addiction treatment and mental health services after acute poisoning, significant cost differentials exist between countries. Inpatient addiction rehabilitation programmes in India cost $500–2,000 per month compared to $15,000–30,000 per month at US residential programmes. Psychiatric follow-up consultations in India and Thailand typically cost $20–50 per session compared to $150–400 in the US. These cost differences are relevant for expatriates or uninsured individuals requiring extended mental health or addiction care following a poisoning episode.

In acute poisoning emergencies, there are no alternatives to evidence-based emergency medical care. Inducing vomiting at home using syrup of ipecac is no longer recommended — it does not reliably remove poison, delays administration of activated charcoal, and can cause aspiration. Salt water should never be used to induce vomiting in children (potentially fatal sodium toxicity has occurred).

For long-term management after opioid overdose, medication-assisted treatment (MAT) using buprenorphine/naloxone (Suboxone) or methadone reduces opioid use, overdose risk, criminal behaviour, and mortality in opioid use disorder — with overwhelming evidence of benefit compared to abstinence-only approaches. Naloxone take-home programmes, in which at-risk opioid users and their families are trained and equipped with naloxone auto-injectors, represent a major public health strategy that has reversed thousands of out-of-hospital opioid overdose deaths in countries that have implemented them widely.